Overview of the risks of Staphylococcus aureus infections and their control by bacteriophages and bacteriophage-encoded products

Braz J Microbiol. 2021 Jul 12. doi: 10.1007/s42770-021-00566-4. Online ahead of print.

ABSTRACT

Staphylococcus aureus is the leading cause of secondary infections in hospitals and a challenging pathogen in food industries. Decades after it was first reported, β-lactam-resistant S. aureus remains a subject of intense research owing to the ever-increasing issue of drug resistance. S. aureus bacteriophages (phages) or their encoded products are considered an alternative to antibiotics as they have been shown to be effective in treating some S. aureus-associated infections. In this review, we present a concise collection of the literature on the pathogenic potential of S. aureus and examine the prospects of using S. aureus phages and their encoded products as antimicrobials.

PMID:34251609 | DOI:10.1007/s42770-021-00566-4